Blank CU - Search Results

1

Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.

Li H, van der Leun AM, Yofe I, Lubling Y, Gelbard-Solodkin D, van Akkooi ACJ, van den Braber M, Rozeman EA, Haanen JBAG, Blank CU, Horlings HM, David E, Baran Y, Bercovich A, Lifshitz A, Schumacher TN, Tanay A, Amit I. Li H, et al. Among authors: blank cu. Cell. 2019 Feb 7;176(4):775-789.e18. doi: 10.1016/j.cell.2018.11.043. Epub 2018 Dec 27. Cell. 2019. PMID: 30595452 Free PMC article.

2

Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery.

Bex A, van der Veldt AA, Blank C, van den Eertwegh AJ, Boven E, Horenblas S, Haanen J. Bex A, et al. World J Urol. 2009 Aug;27(4):533-9. doi: 10.1007/s00345-008-0368-7. Epub 2009 Jan 15. World J Urol. 2009. PMID: 19145434

3

Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers.

Hadrup SR, Bakker AH, Shu CJ, Andersen RS, van Veluw J, Hombrink P, Castermans E, Thor Straten P, Blank C, Haanen JB, Heemskerk MH, Schumacher TN. Hadrup SR, et al. Nat Methods. 2009 Jul;6(7):520-6. doi: 10.1038/nmeth.1345. Epub 2009 Jun 21. Nat Methods. 2009. PMID: 19543285

4

RNA interference targeting programmed death receptor-1 improves immune functions of tumor-specific T cells.

Borkner L, Kaiser A, van de Kasteele W, Andreesen R, Mackensen A, Haanen JB, Schumacher TN, Blank C. Borkner L, et al. Cancer Immunol Immunother. 2010 Aug;59(8):1173-83. doi: 10.1007/s00262-010-0842-0. Epub 2010 Mar 27. Cancer Immunol Immunother. 2010. PMID: 20349059

5

A phase II study of presurgical sunitinib in patients with metastatic clear-cell renal carcinoma and the primary tumor in situ.

Bex A, Blank C, Meinhardt W, van Tinteren H, Horenblas S, Haanen J. Bex A, et al. Urology. 2011 Oct;78(4):832-7. doi: 10.1016/j.urology.2011.05.034. Epub 2011 Jul 29. Urology. 2011. PMID: 21802123 Clinical Trial.

6

Combination of targeted therapy and immunotherapy in melanoma.

Blank CU, Hooijkaas AI, Haanen JB, Schumacher TN. Blank CU, et al. Cancer Immunol Immunother. 2011 Oct;60(10):1359-71. doi: 10.1007/s00262-011-1079-2. Epub 2011 Aug 17. Cancer Immunol Immunother. 2011. PMID: 21847631 Review.

7

Ipilimumab-induced sarcoidosis in a patient with metastatic melanoma undergoing complete remission.

Vogel WV, Guislain A, Kvistborg P, Schumacher TN, Haanen JB, Blank CU. Vogel WV, et al. Among authors: blank cu. J Clin Oncol. 2012 Jan 10;30(2):e7-e10. doi: 10.1200/JCO.2011.37.9693. Epub 2011 Nov 28. J Clin Oncol. 2012. PMID: 22124094 No abstract available.

8

Reduced tumor-antigen density leads to PD-1/PD-L1-mediated impairment of partially exhausted CD8⁺ T cells.

Kaiser AD, Schuster K, Gadiot J, Borkner L, Daebritz H, Schmitt C, Andreesen R, Blank C. Kaiser AD, et al. Eur J Immunol. 2012 Mar;42(3):662-71. doi: 10.1002/eji.201141931. Epub 2012 Jan 23. Eur J Immunol. 2012. PMID: 22144176 Free article.

9

Targeting BRAFV600E in an inducible murine model of melanoma.

Hooijkaas AI, Gadiot J, van der Valk M, Mooi WJ, Blank CU. Hooijkaas AI, et al. Among authors: blank cu. Am J Pathol. 2012 Sep;181(3):785-94. doi: 10.1016/j.ajpath.2012.06.002. Epub 2012 Jul 11. Am J Pathol. 2012. PMID: 22796458

10

Selective BRAF inhibition decreases tumor-resident lymphocyte frequencies in a mouse model of human melanoma.

Hooijkaas A, Gadiot J, Morrow M, Stewart R, Schumacher T, Blank CU. Hooijkaas A, et al. Among authors: blank cu. Oncoimmunology. 2012 Aug 1;1(5):609-617. doi: 10.4161/onci.20226. Oncoimmunology. 2012. PMID: 22934253 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

306 results

Search Page